RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재

      항당뇨약 Rosiglitazone의 혈관 수축성에 대한 이중성 조절 = Biphasic Effects of Rosiglitazone on Agonist-induced Regulation of Vascular Contractility

      한글로보기

      https://www.riss.kr/link?id=A103781313

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Rosiglitazone ($Avandia^{(R)}$) represents a new class of antidiabetic drugs which are $PPAR{\gamma}$ agonists. The present study was undertaken to determine whether the new antidiabetic rosiglitazone influences on the agonist-induced regulation of va...

      Rosiglitazone ($Avandia^{(R)}$) represents a new class of antidiabetic drugs which are $PPAR{\gamma}$ agonists. The present study was undertaken to determine whether the new antidiabetic rosiglitazone influences on the agonist-induced regulation of vascular smooth muscle contraction as an antihypertensive and, if so, to investigate the related mechanism. Endothelium-denuded arterial rings from male Sprague-Dawley rats were used and isometric contractions were recorded using a computerized data acquisition system. Rosiglitazone decreased Rho-kinase activating agonist (NaF or thromboxane $A_2$ mimetic)-induced contraction but not depolarization- or phorbol ester-induced contraction. Surprisingly, it slightly potentiated the latter contraction possibly opening a voltage-dependent calcium channel by its chemical structure on 50 mM KCI- or $1{\mu}M$ phorbol 12,13-dibutyrate-induced vasoconstriction. In conclusion, this study provides the evidence and possible related mechanism concerning the biphasic effect of an antidiabetic rosiglitazone as a possible antihypertensive on the agonistinduced contraction in rat aortic rings regardless of endothelial function.

      더보기

      참고문헌 (Reference)

      1 "triphosphate in activating the poly- phosphoinositide phosphodiesterase of hepatocyte mem- branes. Role for the guanine nucleotide regulatory protein Gp in signal transduction. Biochem. J. 241" 1987

      2 "Thromboxane A2-induced contraction of rat caudal arterial smooth muscle involves activation of Ca2+ entry and Ca2+ sensitization: Rho-associated kinase-mediated pho- sphorylation of MYPT1 at Thr-855, but not Thr-697" 389 : 763-, 2005

      3 "Studies on the hepatic calcium-mobilizing activity of aluminum fluoride and glucagon. Modulation by cAMP and phorbol myristate acetate. J. Biol. Chem. 261" 1986

      4 Gohla A, "Roles for G(12)/G(13) in agonist-induced vascular smooth muscle cell con- traction." 87 : 221-, 2000

      5 Cobine C. A, "Role of L-type calcium channels and PKC in active tone development in rabbit coronary artery." 292 (292): H3079-, 2007

      6 T, "Protein-mediated inhibition of myosin light-chain phosphatase in vascular smooth muscle. Proc. Natl. Acad. Sci. USA 88" 1991

      7 Amano M, "Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase)." 271 : 20246-, 1996

      8 "Peroxisome proliferators-activated receptor gamma ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferator-activated receptor gamma-dependent mechanisms" 25 (25): 1810-, 18102005

      9 Touyz R. M, "Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications." 45 : 19-, 2006

      10 Kurtz T. W, "New treatment strategies for patients with hypertension and insulin resistance" 119 : S24-, 2006

      1 "triphosphate in activating the poly- phosphoinositide phosphodiesterase of hepatocyte mem- branes. Role for the guanine nucleotide regulatory protein Gp in signal transduction. Biochem. J. 241" 1987

      2 "Thromboxane A2-induced contraction of rat caudal arterial smooth muscle involves activation of Ca2+ entry and Ca2+ sensitization: Rho-associated kinase-mediated pho- sphorylation of MYPT1 at Thr-855, but not Thr-697" 389 : 763-, 2005

      3 "Studies on the hepatic calcium-mobilizing activity of aluminum fluoride and glucagon. Modulation by cAMP and phorbol myristate acetate. J. Biol. Chem. 261" 1986

      4 Gohla A, "Roles for G(12)/G(13) in agonist-induced vascular smooth muscle cell con- traction." 87 : 221-, 2000

      5 Cobine C. A, "Role of L-type calcium channels and PKC in active tone development in rabbit coronary artery." 292 (292): H3079-, 2007

      6 T, "Protein-mediated inhibition of myosin light-chain phosphatase in vascular smooth muscle. Proc. Natl. Acad. Sci. USA 88" 1991

      7 Amano M, "Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase)." 271 : 20246-, 1996

      8 "Peroxisome proliferators-activated receptor gamma ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferator-activated receptor gamma-dependent mechanisms" 25 (25): 1810-, 18102005

      9 Touyz R. M, "Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications." 45 : 19-, 2006

      10 Kurtz T. W, "New treatment strategies for patients with hypertension and insulin resistance" 119 : S24-, 2006

      11 Somlyo A. P, "From pharmacomechanical coupling to G-proteins and myosin phosphatase" 164 : 437-, 1998

      12 "Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes." 356 (356): 2457-, 2007

      13 Panchapakesan U, "Drug insight: thiazolidinediones and diabetic nephropathy--relevance to renoprotection" 1 : 33-, 2005

      14 Nobe K, "Distinct pathways of Ca2+ sensitization in porcine coronary artery: effects of Rho-related kinase and protein kinase C inhibition on force and intracellular Ca2+" 88 : 1283-, 2001

      15 "Comparison of inhibitory effects of Y-27632, a Rho kinase inhibitor, in strips of small and large mesenteric arteries from spontaneously hypertensive and normotensive Wistar-Kyoto rats" 26 : 97-, 2003

      16 Chetty V. T, "Can PPARgamma agonists have a role in the management of obesity related hyper- tension?" 45 : 46-, 2006

      17 Uehata M, "Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension" 389 : 990-, 1997

      18 Sakurada S, "Ca2+-dependent activation of Rho and Rho-kinase in membrane depolarization-induced and receptor stimulation-induced vascular smooth muscle con- traction" 93 : 548-, 2003

      19 "A role for Rho kinase in vascular contraction evoked by sodium fluoride. Biochem" 343 (343): 27-, 2006

      20 Leung T, "A novel serine/threonine kinase binding the Ras-related RhoA GTPase which translocates the kinase to peripheral membranes." 270 : 29051-, 1995

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2027 평가예정 재인증평가 신청대상 (재인증)
      2021-01-01 평가 등재학술지 유지 (재인증) KCI등재
      2018-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2015-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2007-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2004-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2003-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2002-01-01 평가 등재후보학술지 유지 (등재후보1차) KCI등재후보
      1999-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.2 0.2 0.22
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.23 0.18 0.403 0.02
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼